Temple University Hospital

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

Retrieved on: 
Tuesday, March 7, 2023
Software, Practice Management, Telemedicine, Virtual Medicine, Health, Medical Devices, Hospitals, Health Technology, Technology, Life, Radius, Sepsis, Uniview, MASI, RN, Patient, Multimedia, Nursing, Temple Health, MSN, FDA, Health equity, Automation, Associate, Temple University Hospital, Medical device, Masimo

Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health , Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration.

Key Points: 
  • Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health , Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration.
  • The collaboration is designed to further the organizations’ mutual goals of improving health, increasing care value, and transforming models of care delivery.
  • View the full release here: https://www.businesswire.com/news/home/20230307005243/en/
    Joseph DiMartino, MSN, RN, Associate Vice President of Nursing at Temple University Hospital, said, “Temple Health is committed to driving medical advances through clinical innovation, pioneering research and world-class education.
  • Participation in the Temple Health “Collaboratory,” where the latest Masimo technologies will be trialed and refined before broader deployment.

Dr. Cherag Daruwala of Hunterdon Gastroenterology Awarded As NJ Top Doc

Retrieved on: 
Tuesday, January 31, 2023
Hunterdon Medical Center, Associate, Temple University Hospital, Patient, Irritable bowel syndrome, Hepatitis, Cancer, Diagnosis, Medical device, Hepatology, Central Jersey, Gastroenterology

SCOTCH PLAINS, N.J., Jan. 31, 2023 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2022. This is Dr. Daruwala's seventh consecutive year being reviewed and approved by NJ Top Docs. Dr. Daruwala is a board certified Gastroenterologist and Hepatologist.

Key Points: 
  • NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2022.
  • SCOTCH PLAINS, N.J., Jan. 31, 2023 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2022.
  • After completing his fellowship in Gastroenterology, Dr. Daruwala went on to complete training in endoscopic ultrasound and was on staff at Temple University Hospital for 3 years prior to joining Hunterdon Gastroenterology Associates in 2012.
  • However, I am also receptive to patients who prefer a more holistic approach to treatment," says Dr. Daruwala.

Phillip A. Villanueva, MD, ABNS, is recognized by Continental Who's Who

Retrieved on: 
Monday, January 16, 2023
American Association of Neurological Surgeons, Mentorship, Continental, Critical care, Bachelor of Science in Human Biology, St. Thomas University (Florida), University, Neurology, Brain, ABNS, American Board of Commissioners for Foreign Missions, Certification, Philosophy, Theology, St. Thomas University, Biology, Neuro, Medical degree, General surgery, Congress of Neurological Surgeons, Chemistry, Temple University, Multimedia, Neuroscience, Temple University Hospital, Dentistry, MD, Health care, Medicine, Neurosurgery, Science

Dr. Villanueva has more than 47 years in practice and specializes in surgeries for brain injuries and neuro-critical care.

Key Points: 
  • Dr. Villanueva has more than 47 years in practice and specializes in surgeries for brain injuries and neuro-critical care.
  • He is a member of the American Association of Neurological Surgeons, where he serves on the subcommittee for neuro-critical care.
  • Dr. Villanueva has been the recipient of the Best Doctors in America Award in Neurological Surgery (2019-2020) and numerous other accolades.
  • He would like to dedicate this honor to his mentors, Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.

ixlayer Announces Formation of Advisory Board

Retrieved on: 
Tuesday, November 1, 2022
Technology, Health Technology, Telemedicine, Virtual Medicine, Software, Practice Management, Other Health, General Health, Pharmaceutical, Health, Data Management, GSK, Retirement, Pharmacy, United States Coast Guard Auxiliary, COPE, Morristown Medical Center, COVID-19, Hospital, MHRI, Foundation, Kaiser Permanente, The Honourable, DTRA, Solution, GlaxoSmithKline, Clinton Foundation, Outreach, Operation Warp Speed, Board, Director, Head, Global Vaccines, Research, University, Veterans' affairs, Patient, Multimedia, University of Pennsylvania Health System, Senior, Movement, Drexel University School of Public Health, The Co Founder, Medical college, Editorial board, Time, Health, Decentralized Trials & Research Alliance, Therapeutic Innovation & Regulatory Science, Founder, Sarcoidosis, Pfizer, Salesforce, Health care, Hospital of the University of Pennsylvania, Innovation, Aetna, Government, Temple University Hospital, Pharmaceutical industry, Management, Medicine

ixlayer , the leading platform for health testing, announces today the formation of the ixlayer Health Testing Advisory Board .

Key Points: 
  • ixlayer , the leading platform for health testing, announces today the formation of the ixlayer Health Testing Advisory Board .
  • The ixlayer Health Testing Advisory Board will consist of industry leaders and experts who will serve as thought partners and strategists to further the movement of making health testing more accessible and affordable.
  • View the full release here: https://www.businesswire.com/news/home/20221101005418/en/
    ixlayer is appointing five members to its recently established ixlayer Heath Testing Advisory Board (iHTAB).
  • ixlayer is excited to take these next bold steps on our journey and welcomes these talented and respected professionals to our new advisory board, said Pouria Sanae , ixlayers Chief Executive Officer and co-founder.

Top Healthcare Executives Join Kaia Health’s Newly Created Advisory Board

Retrieved on: 
Thursday, October 13, 2022
Technology, Medical Devices, Fitness & Nutrition, Health Technology, Telemedicine, Virtual Medicine, Software, Biotechnology, Physical Therapy, Health, People, Health, Apple, Veteran, McKinsey & Company, Therapy, Medicine, COPD, Hospital, Growth, Partner, Smartphone, COO, General counsel, Patient, Kaia, MSK, Medical college, University of Pennsylvania Health System, Technology, Modern Healthcare, Forrester Research, University, Morristown Medical Center, Company, Blue Cross Blue Shield Association, The Honourable, AI, Board, CEO, Altran Praxis, DTA, Safety, Lists of diseases, Hospital of the University of Pennsylvania, Advisory board, The Advisory Board Company, ACA, Program, Temple University Hospital, Leadership, Pharmaceutical industry, Management, Healthcare

Kaia Health , the largest global digital therapeutics company on a mission to deliver the most effective digital therapies anytime, anywhere, today announced the appointment of four industry leaders to its newly created Advisory Board.

Key Points: 
  • Kaia Health , the largest global digital therapeutics company on a mission to deliver the most effective digital therapies anytime, anywhere, today announced the appointment of four industry leaders to its newly created Advisory Board.
  • is an accomplished executive who has devoted his career to making a positive impact across the healthcare value chain.
  • Steve serves on a number of boards and as a senior advisor to many of the leading players in healthcare.
  • I am honored to join the Advisory Board and support Kaias mission to advance the availability, quality and affordability of healthcare."

Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems

Retrieved on: 
Tuesday, October 11, 2022
Hospitals, Health, Pharmaceutical, Health Technology, Managed Care, U.S. Securities and Exchange Commission, Efficiency, Population, Pharmacy, CPDS, Temple, Intelligence, Patient, Annual report, Program, Investment, Nasdaq, Partnership, Technology, Private Securities Litigation Reform Act, Automation, Goal, Cyberattack, Prescription, Health, Patient safety, United Kingdom, Forward-looking statement, Approximation error, COVID-19, OMCL, Conditional sentence, Solution, Benchmarking, Temple University Hospital, Hospital, Healthcare, Risk management, Omnicell

Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.

Key Points: 
  • Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.
  • Establishing and optimizing a specialty pharmacy can be an important step for any hospital looking to support access, enhance patient care, and drive revenue in the growing specialty medication market.
  • Specialty Pharmacy Services is a comprehensive offering designed to help health systems launch and/or optimize a fully managed, hospital-owned specialty pharmacy.
  • With the launch of our Specialty Pharmacy Services and enhancements to our advanced services portfolio, Omnicell continues its efforts to deliver optimized clinical and financial outcomes for our customers across all care settings.

Joanne S. Warren, MD, is recognized by Continental Who's Who

Retrieved on: 
Monday, October 10, 2022
Veteran, Medicine, Anesthesiology, Drexel University College of Medicine, Anesthesia, United States Department of Veterans Affairs, Patient, Sleep, Medical college, Goal, MD, Reading, Tuskegee Veterans Administration Medical Center, St Luke's, Mount Sinai West, Safety, Continental, Addiction medicine, Luke the Evangelist, Temple University Hospital, Dentistry

WOODSTOCK, Md., Oct. 10, 2022 /PRNewswire/ -- Joanne S. Warren, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional, acknowledging her excellence as an Anesthesiologist at the Veterans Administration.

Key Points: 
  • WOODSTOCK, Md., Oct. 10, 2022 /PRNewswire/ -- Joanne S. Warren, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional, acknowledging her excellence as an Anesthesiologist at the Veterans Administration.
  • With over 20 years in the medical field, Dr. Joanne S. Warren specializes in anesthesiology and started working with the Veterans Administration last year.
  • As a trusted anesthesiologist, Dr. Warren ensures the safety of patients about to undergo surgery.
  • One of the doctor's future goals is to work with a teaching hospital so that she can mentor new and learning medical professionals.

Phillip A. Villanueva, MD, ABNS, is being recognized by Continental Who's Who

Retrieved on: 
Thursday, September 29, 2022
Neuro, University, American Board of Commissioners for Foreign Missions, Chemistry, Medical degree, Temple University Hospital, Neurology, Critical care, St. Thomas University (Florida), Temple University, Philosophy, American Association, Theology, Certification, Biology, American Association of Neurological Surgeons, General surgery, St. Thomas University, Congress of Neurological Surgeons, Neuroscience, Association, Brain, ABNS, Awareness, Mentorship, Continental, Dentistry, Science, MD, Neurosurgery, Medicine

A highly trained neurosurgeon with 47 years of experience in his field, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care.

Key Points: 
  • A highly trained neurosurgeon with 47 years of experience in his field, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care.
  • For the past eight years, he has served as the Director of Neuro Trauma and Critical Care at Temple University Hospital in Philadelphia, PA.
  • He additionally serves as a Professor of Clinical Neurosurgery at the Lewis Katz School of Medicine at Temple University.
  • He would like to dedicate this honor to his mentors, Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.

Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer

Retrieved on: 
Tuesday, September 20, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Safety, Risk, SMA, FAQ, Human, COVID-19, Nagesh, Twitter, Fibrosis, Research, Securities Act of 1933, Â, Hoechst AG, Temple University Hospital, LinkedIn, Company, Part, Review, Private Securities Litigation Reform Act, Spinal muscular atrophy, Social media, Growth, Investor, Temple University School of Medicine, U.S. Securities and Exchange Commission, Patient, File, Clinical trial, Cancer, CEO, IQVIA, Interim, Acceleron Pharma, Internal medicine, Board of directors, Leadership, Intellectual property, NASDAQ, Rock, Board, Security (finance), R, Multimedia, Celgene, Merck, Neuromuscular Disorders, Public health, Management, Pharmaceutical industry, Director, Gongshi

He most recently served as Executive Vice President, Research and Development at Acceleron Pharma, which was acquired by Merck in 2021.

Key Points: 
  • He most recently served as Executive Vice President, Research and Development at Acceleron Pharma, which was acquired by Merck in 2021.
  • Jay is an exceptional executive leader with a track record of success that spans several decades in the biopharmaceutical industry.
  • I would like to thank Nagesh for his remarkable leadership and commitment to Scholar Rock during his 10-year tenure at the company.
  • Scholar Rock is a registered trademark of Scholar Rock, Inc. REBLOZYL is a registered trademark of Celgene Corporation.

Phillip A. Villanueva, MD, ABNS, is being recognized by Continental Who's Who

Retrieved on: 
Tuesday, August 2, 2022
Association, ABNS, Chemistry, University, Awareness, Temple University Hospital, Brain, Neuroscience, Critical care, St. Thomas University (Florida), American Association of Neurological Surgeons, Neurology, American Association, Continental, Multimedia, General surgery, Neuro, Philosophy, Certification, Mentorship, Temple University, Theology, Congress of Neurological Surgeons, St. Thomas University, Biology, Medical degree, American Board of Commissioners for Foreign Missions, Dentistry, Medicine, Neurosurgery, MD, Science

A highly trained neurosurgeon with 47 years of experience in his field, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care.

Key Points: 
  • A highly trained neurosurgeon with 47 years of experience in his field, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care.
  • For the past eight years, he has served as the Director of Neuro Trauma and Critical Care at Temple University Hospital in Philadelphia, PA.
  • He additionally serves as a Professor of Clinical Neurosurgery at the Lewis Katz School of Medicine at Temple University.
  • Dr. Villanueva is a member of the American Association of Neurological Surgeons, where he sits on the subcommittee for neuro-critical care.